There is a new migraine prevention medicine out there that is causing a lot of excitement in the chronic migraine sufferers of the world. Aimovig/Erenumab is the first and only FDA-approved Calcitonin Gene-Related Peptide (CGRP) receptor blocker and my friends who have been battling debilitating migraine pain for years are eager to try it.
You can learn more about this at Aimovig. It is available by prescription only and right now reports are coming in that the manufacturer has been overwhelmed by the demand and there may be a wait to get this self-injectable monthly migraine preventative.
Will it work for everyone? The magic 8 ball says, “Probably not.”
That is the case for any medication, my friends. It will help some more than others, and often for reasons we don’t know or understand. But it is definitely worth having a conversation with your doctor if you suffer from chronic or episodic migraines and you have tried all of the usual suspects without lasting relief. The manufacturer is careful to say that it will lessen the number of migraines you have, not eliminate them completely.
Now, here’s a question…Could it help with Burning Mouth Syndrome pain?
Only time and usage will tell. BMS sufferers can be a subset of the larger number of people who suffer from migraines, but some are not. I have had chronic migraines for nearly twenty years and will be trying this medication as soon as my local pharmacy receives it. I will let you know if I perceive any relief of my primary BMS. This will be anecdotal, of course, and I have no expectation that any research will be done any time soon on this medicine’s effect on other chronic pain syndromes.